| 1. |
Quintiliani R，Cooper BW，Briceland LL，et al.Economic impact of streamlining antibiotic administration.Am J Med，1987，82：391-394.
|
| 2. |
Ramirez JA，Srinath L，Ahkee S，et al.Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia.Arch Intern Med，1995，155：1273-1276.
|
| 3. |
Khan F，Karnik A.Clinical uses of sequential IV/PO ciprofloxacin vs ceftazidime in serious bacterial infections [abstract 139].Abstracts of the Ninth Mediterranean Congress on Chemother，Milan，Italy，1994.
|
| 4. |
Paladino JA，Sperry HE，Backes JM，et al.Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics.Am J Med，1991，91：462-470.
|
| 5. |
Aujesky D，Auble TE，Yealy DM，et al.Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.Am J Med，2005，118：384-392.
|
| 6. |
Ramirez JA，Srinath L，Ahkee S，et al.Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia.Arch Intern Med，1995，155：1273-1276.
|
| 7. |
Ramirez JA.Switch therapy in community-acquired pneumonia.Diagn Microbiol Infect Dis，1995，22：219-223.
|
| 8. |
Kollef MH，Sherman G，Ward S，et al．Inadequate antimicrobial treatment of infections：a risk factor for hospital mortality among critically ill patients．Chest，1999，115：462-474.
|
| 9. |
Ibrahim EH，Sherman G，Ward S，et al．The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.Chest，2000，118：146-155.
|
| 10. |
賈東崗，雷招寶.抗生素的序貫療法及其研究進展.藥物實踐雜志，2004，22：144-148.
|
